trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Metoprolol succinate extended-release tablets are designed for once-daily administration.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Metoprolol succinate extended-release tablets are designed for once-daily administration?

Yes. Metoprolol succinate extended-release tablets are formulated to provide 24-hour efficacy, allowing for once-daily administration in clinical practice.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked

The analysis

The claim is a specific, empirical pharmacological fact about the dosing frequency of metoprolol succinate extended-release tablets. Multiple retrieved studies (such as papers 2, 4, and 10) explicitly reference or utilize metoprolol succinate as a once-daily medication. There is no contradictory evidence in the provided papers.

Evidence for · 3
A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence.
2022
Get citation
SA, M., S, K., N, E. R., K, L., VV, E., Y, G., Y, C., D, E., K, F., H, K., M, K., T, L., Z, L., SOF, S., JA, J., RF, F., LL, F., L, Z., PF, B., S, S., & LH, C. (2022). A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence.. doi.org. https://doi.org/10.1111/cts.13294

See more details
More for · 2
Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.
2026
Get citation
A, P., N, K., SK, R., F, K., K, Y., MS, U., MW, S., AK, J., JD, C., M, B., ZL, C., JT, T., C, A., DK, G., A, C., MH, D., MT, H., VG, Z., & TJ, W. (2026). Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.. doi.org. https://doi.org/10.1038/s41591-026-04504-5

Factors Influencing Internal Medicine Resident Beta-Blocker Discontinuation in Acute Decompensated Heart Failure.
2025
Get citation
D, B., SB, B., G, D., MD, P., N, B., & CG, O. (2025). Factors Influencing Internal Medicine Resident Beta-Blocker Discontinuation in Acute Decompensated Heart Failure.. doi.org. https://doi.org/10.1016/j.cjco.2025.07.013

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work